This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT06008756
Recruitment Status : Recruiting
First Posted : August 24, 2023
Last Update Posted : April 8, 2024
Information provided by (Responsible Party):
Merck Sharp & Dohme LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 29, 2029
Estimated Study Completion Date : November 29, 2029